Oncoheroes Biosciences and the Super Sam Foundation walking together for the pediatric cancer Blog Post

Oncoheroes Biosciences announces the receipt of funding from Super Sam Foundation, a pediatric cancer nonprofit organization. Oncoheroes is a Boston based biotech with its European headquarters at the Barcelona Science Park. The startup was co-founded in 2017 by Ricardo Garcia, a serial entrepreneur from Barcelona, and the Italian scientist Cesare Spadoni, two parents touched by childhood cancer and determined to change the outlook for these young patients.

 

First foal born in Spain using a procedure which enhances reproductive efficiency and genetic preservation in elite animals Blog Post

The first horse conceived as a result of a combination of ovum pick up (OPU) and intracytoplasmic sperm injection (ICSI), two in vitro fertilisation techniques which enhance fertility and enable the genetic preservation of elite animals, has just been born in Catalonia. This birth points to the future of equine assisted reproduction in Spain. It has been made possible by a project carried out entirely in the country led by the Embryotools centre based in the Barcelona Science Park in partnership with CREA Veterinaris and Embriones Equino.

 

The XIII edition of the Board of Trustees of the UB and the FBG Awards is already open Blog Post

The Awards of the Board of Trustees of the University of Barcelona and the Bosch i Gimpera Foundation for the transfer of knowledge and the creation of innovative companies celebrate their thirteenth edition. These awards aim to promote the return to society of the knowledge acquired through study and research, to stress the importance of technology, knowledge, and innovation transfer projects, and to foster the creation of innovative companies and entrepreneurial culture within the UB Group. The Bosch i Gimpera Foundation is the technology transfer office of the UB since 1983 and is based in the Barcelona Science Park.

 

GalChimia renews the Crédit d’Impôt Recherche (CIR) accreditation Blog Post

GalChimia has renewed the Crédit d’Impôt Recherche (CIR) accreditation from the French Government, which certifies the company as a provider of R&D services in France. The evaluation is related to the company’s participation in the SHIKIFACTORY100 European project, aimed at the production of compounds of high added value in the chemical, food and cosmetic industries. The Galician company has doubled the surface and staff of its R&D&I center at the Barcelona Science Park, which was opened two years ago to accelerate its growth and internationalization strategy. 

 

Genesis Biomed to invest an additional €500,000 in 2020 Blog Post

The Genesis Ventures fund, investment vehicle of several family offices managed by the consulting firm Genesis Biomed, based in the Barcelona Science Park, has announced that it will invest an additional €500,000 in the remainder of this year. The new investments will be made in several of the spin-offs of its portfolio of companies dedicated to biomedical research, in a moment of paralysis due to health and social crisis caused by the SARS-CoV-2 coronavirus.

 

The FDA licenses Chemotargets CLARITY platform Blog Post

Chemotargets –a global leader in the development of intelligence platforms and drug design prediction, headquartered in the Barcelona Science Park– has signed a license agreement for its CLARITY® platform with the Food and Drug Administration (FDA) to provide adverse event predictions and mechanistic investigation in public health risk assessments of new drug applications and existing marketed products.